Anteris Technologies Global (AVR) Cash from Financing Activities (2024 - 2026)
Anteris Technologies Global (AVR) posted quarterly Cash from Financing Activities of $299.5 million for Q1 2026, up 27552.89% year-over-year from N/an in Q1 2025, and up 1238.18% quarter-over-quarter from $22.4 million in Q4 2025.
Anteris Technologies Global (AVR) Cash from Financing Activities (2024 - 2026) Analysis & Trends
Anteris Technologies Global (AVR) has reported Cash from Financing Activities for 3 consecutive years, with $299.5 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Cash from Financing Activities rose 27552.89% year-over-year to $299.5 million; the TTM figure through Mar 2026 stood at $321.2 million (up 191.46% YoY), while the FY2025 annual figure was $20.6 million, down 81.78% from the prior year.
- Cash from Financing Activities rose to $299.5 million in Q1 2026 per AVR's latest filing, from $22.4 million in the prior quarter.
- Across five years, Cash from Financing Activities topped out at $299.5 million in Q1 2026 and bottomed at -$1.1 million in Q1 2025.
- Historically, Cash from Financing Activities has averaged $48.1 million across 3 years, with a median of $14.4 million in 2024.
- Annual changes were most pronounced in 2025 — Cash from Financing Activities sank 170.25% — and 2026, when it soared 27552.89%.
- Anteris Technologies Global's Cash from Financing Activities stood at $78.4 million in 2024, then plunged by 71.45% to $22.4 million in 2025, then jumped by 1238.18% to $299.5 million in 2026.
- Business Quant data shows AVR's Cash from Financing Activities at $299.5 million in Q1 2026, $22.4 million in Q4 2025, and -$294000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Financing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 134.13 Bn | 128.91 Bn | 1.96 Bn | -287.90 Mn |
| 2 | Becton Dickinson | 52.76 Bn | 51.90 Bn | 2.32 Bn | -577.00 Mn |
| 3 | Alcon | 35.81 Bn | 34.46 Bn | 1.68 Bn | -510.00 Mn |
| 4 | Resmed | 33.72 Bn | 32.25 Bn | 861.22 Mn | -263.16 Mn |
| 5 | Medline | 29.38 Bn | 26.70 Bn | 2.22 Bn | -159.00 Mn |
| 6 | West Pharmaceutical Services | 25.00 Bn | 24.57 Bn | 329.20 Mn | -164.80 Mn |
| 7 | Solventum | 15.46 Bn | 15.06 Bn | 1.29 Bn | -300.00 Mn |
| 8 | Cooper Companies | 14.88 Bn | 14.74 Bn | 735.40 Mn | -75.80 Mn |
| 9 | Baxter International | 13.58 Bn | 11.43 Bn | 1.03 Bn | -31.00 Mn |
| 10 | Anteris Technologies Global | 875.09 Mn | 875.09 Mn | 776,000.00 | -877,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -877,000.00 |
| Jun 30, 2026 | -877,000.00 |
| Mar 31, 2026 | 299.51 Mn |
| Mar 31, 2026 | 299.51 Mn |
| Dec 31, 2025 | 22.38 Mn |
| Dec 31, 2025 | 22.38 Mn |
| Sep 30, 2025 | -294,000.00 |
| Sep 30, 2025 | -294,000.00 |
| Jun 30, 2025 | -442,000.00 |
| Jun 30, 2025 | -442,000.00 |
| Mar 31, 2025 | -1.09 Mn |
| Mar 31, 2025 | -1.09 Mn |
| Dec 31, 2024 | 78.40 Mn |
| Dec 31, 2024 | 78.40 Mn |
| Sep 30, 2024 | 18.49 Mn |
| Sep 30, 2024 | 18.49 Mn |
| Jun 30, 2024 | 14.39 Mn |
| Jun 30, 2024 | 14.39 Mn |
| Mar 31, 2024 | 1.55 Mn |
| Mar 31, 2024 | 1.55 Mn |